CME GROUP INC.·5

Mar 15, 4:20 PM ET

Carey Charles P 5

5 · CME GROUP INC. · Filed Mar 15, 2024

Insider Transaction Report

Form 5
Period: 2023-12-31
Transactions
  • Sale

    Class B Common Stock, Series B-3

    2023-10-09$215.76/sh1$2160 total(indirect: By Partnership)
  • Sale

    Class B Common Stock, Series B-4

    2023-10-10$216.09/sh1$2160 total(indirect: By Partnership)
  • Sale

    Class B Common Stock, Series B-2

    2023-10-06$211.93/sh1$2120 total(indirect: By Partnership)
  • Sale

    Class B Common Stock, Series B-1

    2023-10-09$215.76/sh1$2160 total(indirect: By Partnership)
Holdings
  • Common Stock Class A

    (indirect: By Partnership)
    0.375
  • Common Stock Class A

    (indirect: By Trust)
    10,163
  • Common Stock Class A

    (indirect: By Firm)
    185
Footnotes (3)
  • [F1]This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-2 share was sold on October 6, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 6, 2023 was $211.93.
  • [F2]This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-1 share and one Class B-3 share were sold on October 9, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 9, 2023 was $215.76
  • [F3]This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-4 share was sold on October 10, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 10, 2023 was $216.09.

Documents

1 file
  • 5
    wk-form5_1710534001.xmlPrimary

    FORM 5